Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.3%

1 terminated/withdrawn out of 23 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

17%

4 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 2
10(43.5%)
Phase 1
9(39.1%)
Phase 3
4(17.4%)
23Total
Phase 2(10)
Phase 1(9)
Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT07739160Phase 2Not Yet Recruiting

The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients

Role: lead

NCT07404553Phase 2Recruiting

A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors

Role: lead

NCT07349615Phase 3Recruiting

A Study of SHR-1918 In Participants With Hypertriglyceridemia

Role: lead

NCT06700083Phase 1Completed

A Safety, Tolerability, Pharmacokinetic Study of SHR-6934 Injection in Healthy Subjects

Role: lead

NCT07230730Phase 3Recruiting

A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

Role: lead

NCT07280936Phase 1Recruiting

A Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses

Role: lead

NCT07083362Phase 1Completed

Safety, Tolerability and Pharmacokinetic Study of HRS-8829

Role: lead

NCT06825416Phase 3Completed

A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Role: lead

NCT06471218Phase 2Completed

Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

Role: lead

NCT06109831Phase 2Completed

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic

Role: lead

NCT06723652Phase 3Completed

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Role: lead

NCT07230145Phase 1Not Yet Recruiting

A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure

Role: lead

NCT06009393Phase 2Completed

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Role: lead

NCT06732648Phase 2Recruiting

The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction

Role: lead

NCT07133815Phase 2Not Yet Recruiting

Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Role: lead

NCT06220123Phase 2Completed

A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

Role: lead

NCT05330208Phase 1Terminated

Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects

Role: lead

NCT06905314Phase 1Not Yet Recruiting

A Single Ascending Dose of HRS-4029 in Healthy Subjects

Role: lead

NCT05752461Phase 2Completed

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Role: lead

NCT05690711Phase 2Completed

A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction

Role: lead